A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
for Triple Negative Breast Cancer
6 locations incl. Duarte
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Sex: All·Age: 18+
Code: NCT06908928·Phase 1·Recruiting